HELLP syndrome epidemiology and demographics

Jump to navigation Jump to search

HELLP syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating HELLP Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HELLP syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HELLP syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HELLP syndrome epidemiology and demographics

CDC on HELLP syndrome epidemiology and demographics

HELLP syndrome epidemiology and demographics in the news

Blogs on HELLP syndrome epidemiology and demographics

Directions to Hospitals Treating HELLP syndrome

Risk calculators and risk factors for HELLP syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The incidence of HELLP is reported to be 0.2-0.6% of all pregnancies. Of women with preeclampsia, 4-12% also develop signs of a "superimposed" HELLP syndrome. HELLP usually begins during the third trimester, and usually in caucasian women over the age of 25. Rarely, cases have been reported as early as 23 weeks gestation.

References

Template:WH Template:WS